ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

14.62

-1.20 (-7.59%)

Aug 14, 2025, 2:52 PM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Needle-free Intranasal	30.00K	Log In
Needle-free Intranasal Growth	-97.72%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	30.00K	Log In
United States Growth	-97.72%	Log In